etelcalcetide hydrochloride · Medicine question

What is the effective half-life of etelcalcetide hydrochloride when administered intravenously at the end of haemodialysis three times weekly?

Name: What is the effective half-life of etelcalcetide hydrochloride when administered intravenously at the end of haemodialysis three times weekly?
Published: 2026-11-08T13:45:43.465Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Etelcalcetide hydrochloride (Parsabiv) has an effective half-life of 3–5 days when administered intravenously three times weekly at the end of haemodialysis.

Sources for this answer

ParsabivAmgen Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 7Document updated 1 February 2022

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about etelcalcetide hydrochloride